Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy

PURPOSE: Perampanel is a first-in-class antiepileptic medication approved for the treatment of partial (focal) seizures, and as adjunctive treatment for primarily generalized tonic–clonic seizures. The pharmacology, efficacy data, adverse-effect profile, pharmacokinetics and place in therapy are rev...

Descripción completa

Detalles Bibliográficos
Autor principal: Faulkner, Michele A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634370/
https://www.ncbi.nlm.nih.gov/pubmed/29042752
http://dx.doi.org/10.2147/DDDT.S122404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634370/
https://www.ncbi.nlm.nih.gov/pubmed/29042752
http://dx.doi.org/10.2147/DDDT.S122404

Ejemplares similares